Approval · Notice of Compliance 18534 · 2016
THALOMID: Notice of Compliance 18534
Issued September 30, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18534
- Date
- September 30, 2016
- Company
- Celgene IncSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph with data from study cc-5013-mm-020
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THALOMID | Not yet assigned | — |
Medicinal ingredients
- THALIDOMIDE 50 MG per CAP
- THALIDOMIDE 100 MG per CAP
- THALIDOMIDE 200 MG per CAP